Natacha Gassenbach
Public Communications Contact chez BIOGEN INC.
Profil
Natacha Gassenbach is currently the Chief Communication Officer at Biogen, Inc. Prior to this, she held positions as Head of Corporate Affairs at Boston Scientific Corp., Baxalta, Inc., and Novartis Vaccines & Diagnostics, Inc. She also served as the Global Head of Communications & Investor Relations at Stallergenes Greer Ltd.
Gassenbach is a graduate of Sorbonne Université.
Postes actifs de Natacha Gassenbach
| Sociétés | Poste | Début |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | 01/10/2018 |
Anciens postes connus de Natacha Gassenbach
| Sociétés | Poste | Fin |
|---|---|---|
| STALLERGENES GREER | Investor Relations Contact | 01/10/2018 |
| BOSTON SCIENTIFIC CORPORATION | Public Communications Contact | - |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Public Communications Contact | - |
| BAXALTA INC | Public Communications Contact | - |
Formation de Natacha Gassenbach
| Sorbonne Université | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Stallergenes Greer Ltd.
 Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
